Skip to main content

Table 1 Antibodies employed in the immunohistochemical study and results

From: Title: pancreatic‐type mixed acinar neuroendocrine carcinoma of the stomach: a case report and review of the literature

 

Growth pattern

    

Antibody

Acinar-glandular pattern

Solid pattern

Overlying gastric mucosa

Clone

Source

Dilution

BCL-10

+++

++

331.3

Santa Cruz Biotechnology

1:50

Trypsin

+++

++

 

Merck Millipore

1:2000

Chromogranin A

+

+++

SP12

Thermo Fisher Scientific

1:75

Synaptophysin

+

++

SP11

Thermo Fisher Scientific

1:75

CD56

+

++

 

Nichirei Bioscience

prediluted

Amylase

+

+

+

 

Insulin

 

DakoCytomation

1:100

Glucagon

 

DakoCytomation

1:200

Gastrin

 

DakoCytomation

1:300

Serotonin

 

DakoCytomation

1:50

Somatostatin

 

Roche

prediluted

Pancreatic polypeptide

 

DakoCytomation

1:600

β-catenin

+ (cell membrane, cytoplasm)

 

DakoCytomation

1:200

CK7

+

OV-TL12/30

DakoCytomation

1:75

CK19

+

RCK108

DakoCytomation

1:75

CK20

+

KS20.8

DakoCytomation

1:75

CAM5.2

+

+

+

 

Becton, Dickinson and Company

prediluted

CKAE1/AE3

+

+

+

 

DakoCytomation

prediluted